You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 
2013

Breast Cancer: Medication for Risk Reduction (Clinical Guide Recommendation)

Description of Resource: 
The U.S. Preventive Services Task Force recommends that clinicians discuss chemoprevention with women at high risk for breast cancer and at low risk for adverse effects of chemoprevention. Clinicians should inform patients of the potential benefits and harms of chemoprevention.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
U.S. Preventive Services Task Force
Developer Type: 
Federal Government
Healthy People 2020 Topic Area(s): 
Cancer
Healthy People 2020 Objectives: 
Resource Type: 
Systematic Review
Citation: 
U.S. Preventive Services Task Force. Breast Cancer: Medication for Risk Reduction recommendation statement [Internet]. 2013 Sep [cited 2014 Jan 8]. Available from: http://www.uspreventiveservicestaskforce.org/uspstf13/breastcanmeds/breastcanmedsrs.htm